Journal Logo


  • Updated:   3/28/2022
  • Contains:  10 items
This collection highlights the next-generation biomarkers for posttransplantation outcomes.

Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart Transplantation

Lozano-Edo, Silvia; Sánchez-Lázaro, Ignacio; Portolés, Manuel; More

Transplantation. 106(4):887-893, April 2022.

DSA Are Associated With More Graft Injury, More Fibrosis, and Upregulation of Rejection-associated Transcripts in Subclinical Rejection

Höfer, Anne; Jonigk, Danny; Hartleben, Björn; More

Transplantation. 104(3):551-561, March 2020.

Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients

Altuğ, Yücel; Liang, Nathan; Ram, Rosalyn; More

Transplantation. 103(12):2657-2665, December 2019.

High Intrapatient Variability in Tacrolimus Exposure Is Not Associated With Immune-mediated Graft Injury After Liver Transplantation

van der Veer, Marlotte A.A.; Nangrahary, Negina; Hesselink, Dennis A.; More

Transplantation. 103(11):2329-2337, November 2019.

Tolerance Biomarkers in Liver Transplantation: Independent External Validation of the Predictive Strength of SENP6 and FEM1C Gene Expression

Pérez-Sanz, Fernando; Revilla-Nuin, Beatriz; Martínez-Alarcón, Laura; More

Transplantation. 103(9):1887-1892, September 2019.